CLINICAL_TRIALS
trial_result
· 2011-10-03
Clinical Trial Update: Desloratadine 5, 10 and 20mg in Patients With Cold Urticaria [Phase 4]
Summary
A Phase 4 trial evaluated desloratadine at 5, 10, and 20 mg in patients with cold urticaria; the study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Marcus Maurer | Conditions: Urticaria | Phase 4 | Status: COMPLETED